Literature DB >> 21760972

The roles of microRNAs in tumorigenesis and angiogenesis.

Weining Yang, Daniel Y Lee, Yaacov Ben-David.   

Abstract

MicroRNAs (miRNAs) are short, non-coding sequences that control gene expression via translational regulation. Through interactions with the 3'-untranslated region of messenger RNA, miRNAs trigger translational repression and play a key role in developmental timing. Furthermore, many miRNA groups have now been shown to regulate various processes in tumorigenesis, including angiogenesis and metastasis. These links highlight the importance of microRNA research in further understanding cancer development. This review article summarizes the current state of microRNA research, with a focus on the roles of microRNAs in various cancer types. Up to date knowledge of the structure and biogenesis pathway of microRNA are also reviewed.

Entities:  

Keywords:  angiogenesis; biogenesis; cancer; microRNA; tumorigenesis

Year:  2010        PMID: 21760972      PMCID: PMC3134008     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  162 in total

Review 1.  The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

Authors:  Michelle A Carmell; Zhenyu Xuan; Michael Q Zhang; Gregory J Hannon
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

2.  Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines.

Authors:  A Saini; Z Seller; D Davies; J F Marshall; I R Hart
Journal:  Int J Cancer       Date:  1997-10-09       Impact factor: 7.396

3.  Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation.

Authors:  Tim A Rand; Sean Petersen; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

4.  PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation.

Authors:  Peng-Sheng Zheng; Dana Vais; David Lapierre; Yao-Yun Liang; Vivian Lee; Bing L Yang; Burton B Yang
Journal:  J Cell Sci       Date:  2004-11-02       Impact factor: 5.285

5.  miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.

Authors:  Qiang Wang; Yan Chun Li; Jinhua Wang; Juan Kong; Yuchen Qi; Richard J Quigg; Xinmin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

6.  MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.

Authors:  Shireen Kahai; Shao-Chen Lee; Daniel Y Lee; Jennifer Yang; Minhui Li; Chia-Hui Wang; Zide Jiang; Yaou Zhang; Chun Peng; Burton B Yang
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

7.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

8.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

9.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

10.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

View more
  30 in total

1.  Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis.

Authors:  Yang Xia; Yi Zhu; Xiaoying Zhou; Yijiang Chen
Journal:  Tumour Biol       Date:  2014-04-23

Review 2.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Prognostic role of microRNA-100 in various carcinomas: evidence from six studies.

Authors:  Jie Chen; Biqiang Zheng; Chunmeng Wang; Yong Chen; Chunyan Du; Guangfa Zhao; Ye Zhou; Yingqiang Shi
Journal:  Tumour Biol       Date:  2013-11-21

4.  Interrelation of the Circulating and Tissue MicroRNA-21 with Tissue PDCD4 Expression and the Invasiveness of Iraqi Female Breast Tumors.

Authors:  Meena M Abdulhussain; Najat A Hasan; Alaa G Hussain
Journal:  Indian J Clin Biochem       Date:  2017-11-14

Review 5.  miRNAs regulate expression and function of extracellular matrix molecules.

Authors:  Zina Jeyapalan Rutnam; Thomas N Wight; Burton B Yang
Journal:  Matrix Biol       Date:  2012-11-15       Impact factor: 11.583

Review 6.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

7.  Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.

Authors:  Rammohan Devulapally; Kira Foygel; Thillai V Sekar; Juergen K Willmann; Ramasamy Paulmurugan
Journal:  ACS Appl Mater Interfaces       Date:  2016-12-02       Impact factor: 9.229

8.  The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor.

Authors:  Zhaoqun Deng; William W Du; Ling Fang; Sze Wan Shan; Jun Qian; Jiang Lin; Wei Qian; Jichun Ma; Zina Jeyapalan Rutnam; Burton B Yang
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

Review 9.  Diverse roles of miR-335 in development and progression of cancers.

Authors:  Long-Ji Luo; Dan-Dan Wang; Jing Wang; Fan Yang; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-08

10.  MiR-93 enhances angiogenesis and metastasis by targeting LATS2.

Authors:  Ling Fang; William W Du; Weining Yang; Zina Jeyapalan Rutnam; Chun Peng; Haoran Li; Yunxia Q O'Malley; Ryan W Askeland; Sonia Sugg; Mingyao Liu; Tanvi Mehta; Zhaoqun Deng; Burton B Yang
Journal:  Cell Cycle       Date:  2012-10-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.